Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine

Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine     OKLAHOMA CITY (Sept. 20, 2022) — Moat Biotechnology Corporation (MoatBio), a new...
Cortado Ventures Closes Investment With Exum

Cortado Ventures Closes Investment With Exum

OKLAHOMA CITY — December 2021 Cortado Ventures is pleased to announce it closed a Pre-Series A investment with an innovative analytical instrument company. Headquartered in Denver, Exum Instruments brings high-performance, solid-sample chemical characterization out of...